Cardiovascular disease is the leading contributor to years lost due to disability or premature
death among adults. Current efforts focus on risk prediction and risk factor mitigation ‚which …

Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

Methods This document presents the official recommendations of the American
Gastroenterological Association Institute (AGA) on the management of coagulation disorders …

Introduction Hospital-acquired thrombosis accounts for a large proportion of all venous
thromboembolism (VTE), with significant morbidity and mortality. This subset of VTE can be …

Abstract COronavirus Infectious Disease which started in 2019 (COVID‐19) usually presents
with the signs and symptoms of pneumonia. However, a growing number of recent reports …

Importance While hospital-associated venous thromboembolism (HA-VTE) is a known
complication of hospitalization, contemporary incidence and outcomes data are scarce and …

Hypercoagulation is one of the major risk factors for ICU treatment, mechanical ventilation,
and death in critically ill patients infected with SARS-CoV-2. At the same time …

Objective: Estimation of the specific thresholds of the Caprini risk score (CRS) that are
associated with the increased incidence of venous thromboembolism (VTE) across different …

Patient safety is a global public health concern. It is a health care discipline with ever
evolving advancement and complexity resulting in consequential rise in patient harm. Since …

Venous thromboembolism (VTE) is an important vascular disease and public health
problem. Prevention of VTE has focused mainly on using thromboprophylaxis to avoid …